Khan Najat

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 15% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Khan Najat's trades of Recursion Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-10 2026-09-08
PlS Planned sale
38,438 -26.5%
47.03
US$3,971,693 		38,438 -26.5% 47.03 US$3,971,693
2026-09-08 2026-09-08
PrS Proposed sale
48,939
484.37
US$2,544,521 		48,939 484.37 US$2,544,521
2026-06-05 2026-06-05
PlS Planned sale
59,898 +25.3%
289.64
US$291,084 		59,898 +25.3% 289.64 US$291,084
2026-06-05 2026-06-05
PlS Planned sale
23,588 -1.1%
3.58
US$84,459 		23,588 -1.1% 3.58 US$84,459
2026-06-05 2026-06-05
PrS Proposed sale
23,588
3.58
US$84,459 		23,588 3.58 US$84,459
2026-03-11 2026-03-09
PlS Planned sale
28,298 -1.2%
3.35
US$94,660 		28,298 -1.2% 3.35 US$94,660
2026-03-09 2026-03-09
PrS Proposed sale
28,298
3.35
US$94,662 		28,298 3.35 US$94,662
2025-12-29 2025-12-22
PlS Planned sale
124,403 -16.9%
4.41
US$548,592 		124,403 -16.9% 4.41 US$548,592
2025-12-22 2025-12-22
PrS Proposed sale
124,403
4.41
US$548,588 		124,403 4.41 US$548,588
2025-08-19 2025-08-18
S Sale
36,599 -5.2%
5.52
US$202,173 		36,599 -5.2% 5.52 US$202,173
2025-08-18 2025-08-18
PrS Proposed sale
36,599
5.52
US$202,169 		36,599 5.52 US$202,169